Teva Pharmaceutical Industries (TEVA) Preferred Dividend Payments (2015 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Preferred Dividend Payments for 4 consecutive years, with $54.0 million the latest figure, recorded in Q4 2018.

• Quarterly Preferred Dividend Payments fell 16.92% year-over-year to $54.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $249.0 million (down 4.23% YoY) and the FY2018 annual result came in at $249.0 million, down 4.23% from the prior year.
• Preferred Dividend Payments slipped to $54.0 million in Q4 2018 per TEVA's latest filing, from $65.0 million in the prior quarter.
• Over the last five years, Preferred Dividend Payments for TEVA reached as high as $66.0 million in Q1 2016 and fell as low as $15.0 million in Q4 2015.
• A 4-year average of $60.4 million and a median of $65.0 million in 2016 frame the typical range for Preferred Dividend Payments.
• Annual changes were most pronounced in 2016 — Preferred Dividend Payments surged 333.33% — and 2018, when it declined 16.92%.
• Year by year, Preferred Dividend Payments stood at $15.0 million in 2015, then jumped by 333.33% to $65.0 million in 2016, then changed by 0.0% to $65.0 million in 2017, then dropped by 16.92% to $54.0 million in 2018.
• According to Business Quant data, Preferred Dividend Payments over the past three periods registered $54.0 million, $65.0 million, and $65.0 million for Q4 2018, Q3 2018, and Q2 2018 respectively.